NASDAQ: URGN

Business

UroGen Pharma Ltd (NASDAQ:URGN) gain 4.27% – Is It right time to buy?

Noah Smith

UroGen Pharma Ltd (URGN) saw an uptrend of 4.27% in the recent trading with $19.54 being its most recent. The ...

Business

UroGen Pharma Ltd (URGN): The long term indicators on the stock say Buy today

Heidi Phillips

UroGen Pharma Ltd (URGN) saw an uptrend of 1.08% in the recent trading with $23.42 being its most recent. The ...

Business

UroGen Pharma Ltd (URGN): The stock short term indicators are indicating Buy today

Noah Smith

UroGen Pharma Ltd (URGN) saw an uptrend of 1.54% in the recent trading with $23.76 being its most recent. The ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.